Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indications for hormone replacement therapy].

M H Birkhäuser1

  • 1Abteilung für gynäkologische Endokrinologie, UniversitätsFrauenklinik, Inselspital Bern.

Therapeutische Umschau. Revue Therapeutique
|November 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Archives of gynecology and obstetrics·2016
Same author

Archives of gynecology and obstetrics·2016
Same author

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.

Climacteric : the journal of the International Menopause Society·2011
Same author

Quality of life and sexuality issues in aging women.

Climacteric : the journal of the International Menopause Society·2009
Same author

HRT in the early menopause: scientific evidence and common perceptions.

Climacteric : the journal of the International Menopause Society·2008
Same author

Current trends in hormone replacement therapy: perceptions and usage.

Climacteric : the journal of the International Menopause Society·2008
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Hormone Replacement Therapy (HRT) effectively manages menopausal symptoms and metabolic risks, with benefits often outweighing small risks like a slight weight gain or minimal breast cancer increase. Long-term HRT requires individual risk-benefit assessment.

Area of Science:

  • Reproductive Endocrinology
  • Menopause Management
  • Pharmacology

Background:

  • Postmenopausal primary ovarian insufficiency causes climacteric syndrome and estrogen deficiency-related diseases.
  • Hormone Replacement Therapy (HRT) is indicated for symptomatic estrogen deficiency and prevention of osteoporosis, cardiovascular diseases, and Alzheimer's Disease.
  • Tibolone and Raloxifene are recent alternatives to HRT.

Purpose of the Study:

  • To evaluate the therapeutic and preventive role of HRT in postmenopausal women.
  • To address concerns regarding the safety of sexual steroids after menopause.
  • To compare HRT with alternative treatments like Tibolone and Raloxifene.

Main Methods:

  • Review of existing literature and clinical data on HRT, Tibolone, and Raloxifene.

Related Experiment Videos

  • Analysis of HRT's impact on climacteric symptoms, metabolic changes, and disease risk (osteoporosis, cardiovascular disease, Alzheimer's Disease, endometrial and breast cancer).
  • Assessment of HRT's effects on weight, blood pressure, coagulation, and overall mortality.

    • Main Results:

    • HRT is effective for symptomatic estrogen deficiency and offers preventive benefits for specific diseases.
    • HRT is associated with a small weight increase (200-500g) but does not raise blood pressure.
    • The risk of endometrial cancer is not increased with HRT (unless unopposed estrogen is used), and the increase in breast cancer incidence is minimal and not linked to increased mortality; total mortality may decrease up to age 75.

    Conclusions:

    • HRT remains a primary choice for managing menopausal symptoms and metabolic risks, especially when combined.
    • Potential risks of HRT, such as a slight increase in breast cancer incidence, are generally outweighed by benefits like improved quality of life and reduced overall mortality.
    • Individualized assessment of risks and benefits is crucial for long-term HRT indications.